News | August 13, 2025
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Subscribe To Our Newsletter & Stay Updated
